(1) Each delegator, as defined under RCW 18.135.020(6), shall maintain a list of: (a) Specific medications and diagnostic agents, and the route of administration of each, that he or she has authorized for injection; and (b) the vaccines that he or she has authorized for administration. Both the delegator and delegatee shall sign the above list, indicating the date of each signature. The signed list shall be forwarded to the secretary of the department of health and shall be available for review.

     (2) Delegatees are prohibited from administering any controlled substance as defined in RCW 69.50.101(d), any experimental drug, and any cancer chemotherapy agent unless a delegator is physically present in the immediate area where the drug is administered.

[2008 c 58 § 3; 1991 c 3 § 276; 1986 c 216 § 4.]